Presentation to CMO MDs in June 09
1 Addressing the Problem of Medication Non-Adherence Patti Higginbotham, AOCN, APRN Kris Admire, BA.
Community Oncology Conference Ricky Newton, CPA Director of Financial Services and Operations and Treasurer April 24, 2015.
May 2, 2014 State Legislative Update Maine Cancer Consortium Annual Meeting Presentation by Hilary Schneider, State Director of Government Relations and.
A.Pharmacology and the Older Adult B.Psychological and Cognitive Function 1.
A Report from ECCO 14 Oral Chemotherapy in Colorectal Cancer John L. Marshall, MD Chief, Division of Hematology/Oncology Associate Director of Clinical.
Eniluracil Summary. Product Candidate: Eniluracil (EU) 2 Oral Chemotherapy for Solid Tumors Irreversible inhibitor of DPD, the enzyme responsible for.
A Report from ECCO 14 Oral Chemotherapy in Breast Cancer
Ila Saunders, PharmD, BCOP Research Interests Impact of clinical pharmacy services in a matrix cancer center Impact of a “Transitions of Care” clinical.
Understanding the Barriers and Facilitators to Adherence to Oral Chemotherapy in Hispanic Youth with A.L.L. Wendy Landier, MSN, RN, CPNP Cynthia Hughes,
